Pharmaceuticals & Therapeutics

With 65% of its medical tourism revenue from Indonesia, Malaysia is doubling down on its most vital market through strategic outreach and world-class care.

A new competition connects emerging shelf-stable brands with 200+ retail buyers, offering a direct path to national shelf space in a crowded market.

A landmark $41M donation from the Weston family to Sunnybrook aims to overhaul Canada's clinical trial landscape, promising faster patient access to therapies.

Citius Pharmaceuticals raises crucial capital for its new cancer drug, but the deal's structure prompts a classic biotech debate: growth vs. shareholder value.

Millions are using GLP-1 drugs for weight loss, but an unexpected side effect is emerging: a prominent 'buffalo hump' that surgery is now targeting.

A new partnership brings a psychology-based diabetes reversal program to millions, offering a corporate-funded alternative to popular GLP-1 medications.

In a landmark decision, the DEA has rescheduled medical cannabis, unlocking scientific research, slashing industry taxes, and reshaping patient access.

As GLP-1 costs cripple employer health plans, Noom Health's new program bypasses industry middlemen, projecting massive savings and better patient outcomes.

U.S. Anesthesia Partners will settle a major antitrust lawsuit, signaling a victory for federal regulators and new rules for healthcare consolidation.

A new study reveals that poor muscle quality, measured by advanced MRI, is a powerful predictor of death in CKD patients, shifting focus to systemic health.

Canadian giant Apotex acquires Cumberland's U.S. branded drugs for $100M, a move that expands its hospital presence and pivots Cumberland to a biotech.

Backed by military funding, a novel protein therapy that actively grows bone has finished a key clinical trial, promising to revolutionize dental surgery.

A Montreal agency’s innovative campaign for DEX4 is changing the conversation around hypoglycemia by turning a moment of anxiety into an act of empowerment.

A new T-cell therapy, RPTR-1-201, enters clinical trials, offering hope for hard-to-treat solid tumors by targeting a shared, multi-cancer marker.

Winning top awards, China's Fosun Health unveils a bold strategy to become the premier gateway for Southeast Asian patients seeking advanced medical care.

TGA approves Minjuvi, a dual-targeted immunotherapy for relapsed follicular lymphoma, offering a breakthrough option beyond traditional chemotherapy.

An essay contest for medical trainees aims to fix a critical gap in patient care, using frontline stories to reshape how doctors learn about nutrition.

As its leaders vie for a top entrepreneurial award, a look at how GenScript quietly became an indispensable engine for global scientific breakthroughs.

The Pacific Northwest's largest dermatology practice is opening a new clinic in Issaquah, bringing comprehensive skin care to a competitive, growing market.

Hundreds of lupus advocates descended on Washington, demanding policy reform and research funding, and their persistent efforts are already yielding major results.